Evaluation of Anticoagulation Control among Patients Taking Warfarin in University of Gondar Hospital, Northwest Ethiopia
Table 2
Clinical characteristics of patients taking warfarin in University of Gondar hospital, Northwest Ethiopia, from November 1, 2019, to October 31, 2020 (n = 338).
Clinical characteristics
Frequency (no.)
Percentage
BMI (kg/m2)
<18.5
29
8.6
18.5–24.9
229
67.7
25.0–29.9
53
15.7
≥30
27
8.0
Indication for warfarin
Atrial fibrillation
252
74.6
Venous thromboembolism
72
21.3
Prosthetic heart valves
4
1.1
Intracardiac thrombus
10
3.0
Dose of warfarin
<5 mg, daily
199
58.9
5 mg, daily
118
34.9
>5 mg, daily
21
6.2
INR monitoring interval
Every 2 weeks
32
9.5
Every 1 month
283
83.7
Every 2 months
23
6.8
Nonadherence to warfarin
Yes
82
24.3
Concomitant drugs use
Yes
305
90.2
BMI, body mass index; concomitant drugs use included antiplatelets, statins, antihypertensives, antithyroid drugs, and antiretroviral drugs.
